Skip to main content

Advertisement

SpringerLink
Log in

Aflibercept for inflammatory choroidal neovascularization with persistent fluid on intravitreal ranibizumab therapy

  • Letter to the Editor
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Perentes Y, van Tran T, Sickenberg M, Herbort CP (2005) Subretinal neovascular membranes complicating uveitis: frequency, treatments, and visual outcome. Ocul Immunol Inflamm 13:219–224

    Article  PubMed  Google Scholar 

  2. Baxter SL, Pistilli M, Pujari SS, Liesegang TL, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Kempen JH (2013) Risk of choroidal neovascularization among the uveitides. Am J Ophthalmol 156:468–477

    Article  PubMed  Google Scholar 

  3. Neri P, Lettieri M, Fortuna C, Manoni M, Giovannini A (2009) Inflammatory choroidal neovascularization. Middle East Afr J Ophthalmol 16:245–251

    PubMed Central  PubMed  Google Scholar 

  4. Mansour AM, Arevalo JF, Fardeau C, Hrisomalos EN, Chan WM, Lai TY, Ziemssen F, Ness T, Sibai AM, Mackensen F, Wolf A, Hrisomalos N, Heiligenhaus A, Spital G, Jo Y, Gomi F, Ikuno Y, Akesbi J, LeHoang P, Adan A, Mahendradas P, Khairallah M, Guthoff R, Ghandour B, Küçükerdönmez C, Kurup SK (2012) Three-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularization. Can J Ophthalmol 47:269–274

    Article  PubMed  Google Scholar 

  5. Arevalo JF, Adan A, Berrocal MH, Espinoza JV, Maia M, Wu L, Roca JA, Quiroz-Mercado H, Ruiz-Moreno JM, Serrano MA, Pan-American Collaborative Retina StudyGroup (2011) Intravitreal bevacizumab for inflammatory choroidal neovascularization: results from the Pan-American Collaborative Retina Study Group at 24 months. Retina 31:353–363

    Article  CAS  PubMed  Google Scholar 

  6. Tran TH, Fardeau C, Terrada C, Ducos De Lahitte G, Bodaghi B, Lehoang P (2008) Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis. Graefes Arch Clin Exp Ophthalmol 246:1685–1692

    Article  CAS  PubMed  Google Scholar 

  7. Rouvas A, Petrou P, Douvali M, Ntouraki A, Vergados I, Georgalas I, Markomichelakis N (2011) Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization. Retina 31:871–879

    Article  CAS  PubMed  Google Scholar 

  8. Mansour AM, Mackensen F, Mahendradas P, Khairallah M, Lai TY, Bashshur Z (2012) Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularization. Clin Ophthalmol 6:1233–1237

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Freund KB, Mrejen S, Gallego-Pinazo R (2013) An update on the pharmacotherapy of neovascular age-related macular degeneration. Expert Opin Pharmacother 14:1017–1028

    Article  CAS  PubMed  Google Scholar 

  10. Kumar N, Marsiglia M, Mrejen S, Fung AT, Slakter J, Sorenson J, Freund KB (2013) Visual and anatomical outcomes of intravitreal aflibercept in eyes with persistent subfoveal fluid despite previous treatments with ranibizumab in patients with neovascular age-related macular degeneration. Retina 33:1605–1612

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

We have no conflict of interest to declare. I have full access to all data in the study, and I take responsibility for the integrity of the data and accuracy of the data analysis.

All patients signed their informed consent prior to their inclusion in the study.

Author information

Authors and Affiliations

  1. Unit of Macula, Department of Ophthalmology, University and Polytechnic Hospital La Fe, Spain Polytechnic Hospital La Fe, Bulevar Sur, s/n., 46026, Valencia, Spain

    Pablo Hernández-Martínez & Rosa Dolz-Marco

  2. Department of Ophthalmology, University Hospital La Candelaria, Tenerife, Spain

    Marta Alonso-Plasencia & Rodrigo Abreu-Gonzalez

Authors
  1. Pablo Hernández-Martínez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rosa Dolz-Marco
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marta Alonso-Plasencia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rodrigo Abreu-Gonzalez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pablo Hernández-Martínez.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hernández-Martínez, P., Dolz-Marco, R., Alonso-Plasencia, M. et al. Aflibercept for inflammatory choroidal neovascularization with persistent fluid on intravitreal ranibizumab therapy. Graefes Arch Clin Exp Ophthalmol 252, 1337–1339 (2014). https://doi.org/10.1007/s00417-014-2634-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-014-2634-2

Keywords

Search

Navigation